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Infection of mice by murine gammaherpesvirus 68 (MHV-68) is an excellent small-animal model of gam-
maherpesvirus pathogenesis in a natural host. We have carried out comparative studies of another herpesvi-
rus, murine herpesvirus 76 (MHV-76), which was isolated at the same time as MHV-68 but from a different
murid host, the yellow-necked mouse (Apodemus flavicollis). Molecular analyses revealed that the MHV-76
genome is essentially identical to that of MHV-68, except for deletion of 9,538 bp at the left end of the unique
region. MHV-76 is therefore a deletion mutant that lacks four genes unique to MHV-68 (M1, M2, M3, and M4)
as well as the eight viral tRNA-like genes. Replication of MHV-76 in cell culture was identical to that of
MHV-68. However, following infection of mice, MHV-76 was cleared more rapidly from the lungs. In line with
this, there was an increased inflammatory response in lungs with MHV-76. Splenomegaly was also significantly
reduced following MHV-76 infection, and much less latent MHV-76 was detected in the spleen. Nevertheless,
MHV-76 maintained long-term latency in the lungs and spleen. We utilized a cosmid containing the left end
of the MHV-68 genome to reinsert the deleted sequence into MHV-76 by recombination in infected cells, and
we isolated a rescuant virus designated MHV-76(cA81)4 which was ostensibly genetically identical to MHV-68.
The growth properties of the rescuant in infected mice were identical to those of MHV-68. These results
demonstrate that genetic elements at the left end of the unique region of the MHV-68 genome play vital roles
in host evasion and are critical to the development of splenic pathology.
Infection of laboratory mice by murine gammaherpesvirus
68 (MHV-68) (formally designated murid herpesvirus 4) is an
excellent model system for the study of gammaherpesvirus
pathogenesis and for the development of therapeutic strategies
against these viruses (31). Following intranasal inoculation of
mice with MHV-68, productive infection initially occurs in the
lung (34). The acute, productive infection is cleared from the
lung by day 10 postinfection (p.i.) by CD81 T cells (12), but the
virus then persists in a latent form in epithelial cells at this site
(32). MHV-68 spreads to the spleen during the subsequent
viremia, where it becomes latent in B lymphocytes, macro-
phages, and dendritic cells (13, 35, 39, 44). Establishment of
latency in the spleen is associated with a marked splenomegaly
and a mononucleosis that resembles that caused by primary
infection of humans by Epstein-Barr virus (36). Splenomegaly
is driven by CD41 T cells (12, 37) and is dependent on the
presence of MHV-68-infected B cells in the spleen (39, 43).
The resolution of splenomegaly is achieved by CD81 T cells
(12, 43), which are also important in the long-term control of
persistent infection (5, 32, 43).
The MHV-68 genome consists of a unique region of 118,237
bp flanked on each side by multiple copies of a 1,213-bp ter-
minal repeat (11, 42). The left end of the unique region has
attracted considerable interest owing to the presence of four
protein-coding genes (M1, M2, M3, and M4) and eight viral
tRNA-like (vtRNA) genes, all of which lack counterparts in
other gammaherpesviruses (4, 42). Of these, only the function
of M3 has been elucidated. This gene encodes a secreted che-
mokine binding protein that is expressed during acute infection
and persistence in mice (25, 38, 40, 41). M1 has been shown to
be nonessential for lytic replication in vitro and in vivo for the
maintenance and establishment of latency (6, 28). M2 is ex-
pressed during latency in vitro and in vivo (14, 41) and contains
a CD81 T-cell epitope, which is a target for the host immune
response (14, 38). The vtRNA genes are abundantly expressed
during lytic and latent infection (4), but their functional sig-
nificance is not known.
Field studies in Slovakia aimed at identifying a small-animal
vector for flaviviruses resulted in the isolation of five herpes-
viruses from two species of murid rodents (3). MHV-60, -68,
and -72 were isolated from the bank vole (Clethrionomys
glareolus), and MHV-76 and -78 were isolated from the yellow-
necked wood mouse (Apodemus flavicollis). Further molecular
studies of MHV-68 and sequencing of the genome showed that
it belongs to the genus Rhadinovirus (often referred to as
gamma-2 herpesviruses), which includes Kaposi’s sarcoma-as-
sociated herpesvirus and herpesvirus saimiri (HVS) (10, 24, 42).
Of the other herpesvirus strains isolated alongside MHV-68
(3), only MHV-72 has been studied. This virus, which was
isolated from the same host as MHV-68, appears to have
similar biological properties in that it infects B lymphocytes
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(22, 26) and long-term infection is associated with tumorigen-
esis (21). In contrast, MHV-76 was isolated from a different
murid species (3). Therefore, we hypothesized that it may have
different biological characteristics and thus yield additional
insights into gammaherpesvirus pathogenesis. In this paper, we
describe the characterization of MHV-76. We demonstrate
that the MHV-76 genome is essentially identical to that of
MHV-68 except that it lacks M1, M2, M3, M4, and all of the
vtRNA genes. We show that MHV-76 shares many biological
features with MHV-68, including identical growth in vitro,
productive infection in the lung, and the establishment and
maintenance of latency in B lymphocytes. However, it is much
less pathogenic in vivo than MHV-68, and reduced pathoge-
nicity is associated with an increased inflammatory response. A
rescuant virus was constructed by insertion of the left end of
the MHV-68 genome into that of MHV-76. The MHV-76-
derived rescuant regained the in vivo properties of MHV-68.
We conclude that this region of the MHV-68 genome plays an
important role in pathogenesis.
MATERIALS AND METHODS
Cell line and virus. Viruses were grown and titrated using BHK-21 cells as
described previously (34). MHV-68 was originally isolated during field studies
from the bank vole, C. glareolus (3), and was subsequently plaque purified on
BHK-21 cells to obtain clone g2.4 as described by Efstathiou et al. (11). MHV-76
was isolated from the yellow-necked mouse, A. flavicollis, during the same field
study and was plaque purified thrice on BHK-21 cells to obtain a pure stock
Purification of viral DNA. MHV-76 or MHV-68 DNA was prepared from
purified virions as described previously (11). The DNAs migrated as a single
band of high molecular weight by agarose gel electrophoresis and resulted in the
production of infectious virus when transfected into BHK-21 cells (not shown).
For some experiments, high-molecular-weight DNA was also prepared from
infected cells.
Analyses of MHV-76 DNA. Restriction endonuclease digestion and Southern
blot hybridization were carried out using standard procedures. Cosmid clones of
MHV-68 and MHV-76 DNAs were prepared as described previously (7) using
infected-cell DNA and were identified by standard colony hybridization proto-
cols. Pertinent cosmids were an MHV-68 cosmid (cA8) containing nucleotides
115165 to 26842 and an MHV-76 cosmid (cM1) containing the region equivalent
to nucleotides 115587 to 26842. Both cosmids originated from circular or con-
catemeric forms and thus contain both ends of the genome. Nucleotide coordi-
nates are given according to the genome sequence published by Virgin et al. (42).
The DNA sequence of cosmid M1 was determined by standard procedures of
sonication, end repair, and cloning into bacteriophage M13mp19. Inserts were
sequenced using an ABI Prism 377 DNA sequencer, and the data were assem-
bled into the finished sequence using the Sequence Assembly Program (30).
Determination of viral DNA in tissue samples. Viral DNA was extracted from
blood and tissues using QIAmp DNA minikits (Qiagen) according to the man-
ufacturer’s instructions. DNA quantification was performed using a DNA fluo-
rimeter (DyNA Quant 200; Pharmacia). PCR amplification was performed on 1
mg of high-molecular-weight DNA using primers specific for the gp150 or M3
gene as described below. PCR products (15 ml) were electrophoresed through
1.5% agarose gels and analyzed by Southern blot hybridization to confirm the
specificity of the products. DNA was blotted onto Hybond N1 membranes
(Amersham) and hybridized to 32P-labeled probes specific for gp150 or M3.
PCR analysis of viral genomes. PCR amplification was performed using 1 mg
of viral DNA as the template for 40 cycles under conditions described previously
(38). In addition, negative control reactions for all primer sets were performed
using water instead of template DNA (not shown). Primer sequences were as
follows: for M1, 59-GTT ACC TAG GAC ATA CAG TGG-39 and 59-CAG AAC
CTT ACC AGT CAT GTG-39 (product size, 279 bp); for M2, 59-GCG GGA
TCC ATG GCC CCA ACA CCC CCA C-39 and 59-GCG GAA TTC GTT ATG
TTC TGC GTT AGC ACC-39 (product size, 654 bp); for M3, 59-TGG CAC TCA
AAC TTG GTT GTG G-39 and 59-TAA CAG GCA GAT TGC CAT TCC C-39
(product size, 381 bp); for M4, 59-GCG CGG ATC CGA CAC CTG GAG AAG
ATG ATG ATA TTC C-39 and 59-CGC GGA ATT CGG TTC TAG AAA GTC
ATA AAT CTC AAT ACC-39 (product size, 1,452 bp); for gp150, 59-GCG CAA
GCT TCG CCG CCA CCA TGT GTG GCG TTA AAT-39 and 59-CGC GCT
CGA GTT ATT CAT GTA AAC ACA CAC AG-39 (product size, 1,533 bp); and
for ORF 74, 59-GCC ACG ATG CTT GTC CTG CG-39 and 59-TTA GGA GCT
TAG TCT ACA AAC TG-39 (product size, 1,010 bp).
A modification was used to analyze viral plaques or viral stocks. The virus
sample (10 ml; approximately 10 PFU) was added to PCR mix without Taq DNA
polymerase. Proteinase K (Roche) was then added to 0.2 mg/ml. After incubation
at 65°C for 15 min and then at 95°C for 10 min, 1 U of Taq DNA polymerase
(Gibco/BRL) was added and 40 cycles of amplification were performed.
Construction of rescuant viruses. MHV-76 genomic DNA and cosmid A8
were cotransfected into BHK-21 cells by electroporation. After 6 days, the
monolayer was harvested and the supernatant was used to infect BALB/c mice.
After 14 days, the spleens were harvested and analyzed by infective-center assay.
Individual plaques containing rescued virus were identified by PCR amplification
of the M2 and ORF 74 open reading frames (ORFs). Viruses were plaque
purified by limiting-dilution assay on BHK-21 cells until they were homogeneous
by PCR screening.
Southern analysis. High-molecular-weight DNA was isolated from infected
BHK-21 cells and cut with restriction enzymes according to the instructions of
the manufacturer (Gibco/BRL). Southern analysis was then performed by estab-
lished procedures (27), and probes were labeled with 32P using a random-primed
DNA labeling kit (Roche).
In vitro infections. Single-step growth curves were obtained by infecting sub-
confluent BHK-21 cells at a multiplicity of infection (MOI) of 5. After adsorption
for 1 h, the wells were washed with medium to remove unbound virus and fresh
medium was added. At various times p.i., the wells were harvested and infectious
virus was quantified by plaque assay as described below. All experiments were
carried out in duplicate.
Infection of mice and analysis of tissues. BALB/c mice were purchased from
Bantin and Kingman and infected when 4 to 6 weeks old. Mice were anesthetized
with halothane and inoculated intranasally with 2 3 105 PFU of virus in 40 ml of
sterile phosphate-buffered saline. At various times p.i., mice were euthanatized
by cervical dislocation and tissues were harvested for analysis. Plaque assays were
performed using BHK-21 cells to detect infectious virus as described previously
(34). The limit of detection of the plaque assay was 10 PFU per organ. An
infective-center assay was used to detect latent virus as described previously (34).
The data were analyzed statistically using the two-sample t test. P values are
indicated in Results.
Histopathology. After euthanasia by CO2 asphyxiation, the lungs were per-
fused in situ via the trachea using 10% neutral buffered Formol saline. Portions
of spleen were also fixed in 10% buffered Formol saline, and the tissues were
processed routinely into paraffin wax-embedded sections. These were stained
with hematoxylin and eosin and examined by light microscopy.
Nucleotide sequence accession number. The sequence of the MHV-76 insert
in cosmid M1 was deposited with the GenBank data library under accession
number AF324455.
RESULTS
The MHV-76 genome is essentially identical to that of MHV-
68, except for a 9,538-bp deletion at the left end of the unique
region. To assess the genetic differences between MHV-68 and
MHV-76, we compared the restriction fragment banding pat-
terns of the two strains. Figure 1A shows the products of
MHV-68 and MHV-76 DNAs digested with eight restriction
endonucleases cleaving at a total of 185 unique sites. Each
enzyme produced several fragments of identical mobility from
both DNAs, indicating that the genomes are closely related.
However, differences in the restriction profiles were apparent.
Using maps predicted from the MHV-68 genome sequence,
three regions of difference were identified. These are summa-
rized in Fig. 1B.
Two regions correspond to noncoding tandem repeats con-
taining variable copy numbers of 40- or 100-bp elements, at
approximately kbp 27 and 100 in the genome, respectively. The
former region was 0.4 kbp smaller in MHV-76 (approximately
10 copies fewer of the 40 bp element), and the latter region was
1.2 kbp larger (approximately 12 copies more of the 100-bp
element). As examples, relevant bands are indicated for the
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FIG. 1. Structure of the MHV-76 genome. (A) Restriction endonuclease profiles of MHV-68 and MHV-76 virion DNAs. Samples were
analyzed on a 0.8% agarose gel. Fragments E and J are indicated in the HindIII profile of MHV-68. These are absent from the HindIII profile
of MHV-76. Fragments containing the 40-bp repeat (upper pair) and the 100-bp repeat (lower pair) are connected by lines in the SacI profiles of
MHV-68 and MHV-76. Molecular size markers and their sizes in kilobase pairs are indicated to the left. (B) Restriction endonuclease maps of
the unique region of the MHV-68 genome, highlighting the three regions that differ in MHV-76. Variable copy numbers of the terminal repeat
(not shown) flank the unique region, resulting in heterogeneous populations of fragments from the genome termini differing by increments of 1.2
kbp. None of the restriction endonucleases for which maps are shown cleave the terminal repeat. Three regions in which MHV-76 and MHV-68
differ are denoted by thicker horizontal lines. Two correspond to variations in the copy number of reiterations in the 40-bp repeat (at kbp 27) and
100-bp repeat (at kbp 100). The third represents a deletion at the left end. Minimal and maximal extents of the deletion as deduced from panel
A are indicated by thicker and thinner lines, respectively. The location of the insert in MHV-68 cosmid A8 is indicated at the bottom, with terminal
repeat sequences dashed, and the corresponding fragment nomenclature is included in the HindIII map.
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SacI profile in Fig. 1A. Copy number variation in repeats has
long been known to occur in herpesvirus genomes (for exam-
ple, see reference 8).
The third region corresponds to the left end of the unique
region. The profiles were consistent with the absence from the
MHV-76 genome of a sequence which extends in the MHV-68
genome from a position between nucleotides 1 and 111 to a
position between nucleotides 7962 and 10526. As examples,
relevant bands (E and J) are indicated for the HindIII profile
in Fig. 1A. The absence of sequences in HindIII E from
MHV-76 and cosmid M1 (derived from MHV-76 DNA) was
confirmed by Southern blot hybridization (Fig. 2A). The only
other difference detected between the two genomes was the
presence of an additional SphI site in the MHV-76 SphI frag-
ment at nucleotides 32139 to 44301. This could in principle be
the result of a single nucleotide difference.
To characterize the sequence absent from MHV-76 accu-
rately, the sequence of cosmid M1 was determined. In com-
parison with MHV-68, a 9,538-bp region corresponding to the
last nucleotide of the terminal repeat and the first 9,537 bp of
the unique region in MHV-68 was absent from the cosmid. The
absence of this sequence is fully consistent with the genomic
restriction profiles described above. Two minor differences
were also observed between the 21,168-bp sequence of the
cosmid insert and the relevant part of the MHV-68 sequence.
One is trivial, mapping in a GC tract in the terminal repeat
known to be variable in length (24). The other consists of a G
residue at nucleotide 12280 in the coding region for MHV-68
ORF 6, which is present as an A residue in MHV-76, resulting
in substitution of a serine for a glycine residue. This difference
was confirmed by PCR and sequencing of the appropriate
regions of the MHV-68 and MHV-76 DNAs (not shown).
We conclude that MHV-76 and MHV-68 are essentially
identical, except for the absence from MHV-76 of 9,538 bp at
the left end of the unique region. MHV-76 therefore repre-
sents a deletion mutant of MHV-68 or another highly related
virus rather than a distinct viral species.
MHV-76 lacks MHV-68 genes M1, M2, M3, and M4 and
vtRNAs. To check that none of the sequences from the 9,538-bp
deletion are present elsewhere in the genome, MHV-76 DNA
was analyzed by PCR. MHV-76 and MHV-68 genomic DNAs
were tested using primers specific for the M1, M2, M3, M4, and
gp150 genes. The results are shown in Fig. 2B. All of the
sequences assayed were amplified from MHV-68 DNA, but
only the gp150 sequence was amplified from MHV-76 DNA.
These results are consistent with the findings described
above. MHV-76 is thus a deletion mutant of MHV-68 that
lacks M1, M2, M3, most of the 59 portion of M4, and all eight
vtRNA genes. This is depicted schematically in Fig. 2C.
MHV-76 growth in vitro is similar to that of MHV-68.
Figure 3A shows single-step growth curves determined for
MHV-76 and MHV-68 in BHK-21 cells infected at an MOI of
FIG. 2. (A) Autoradiograph of a Southern blot of a 0.8% agarose
gel showing the results of hybridizing radiolabeled HindIII E (isolated
from a plasmid [11]) to the HindIII products of MHV-68 and MHV-76
DNAs and three MHV-68 cosmids (cA8, cA4, and cA13) and one
MHV-76 cosmid (cM1) containing the left end of the genome. The
HindIII E fragment (6,155 bp) is indicated. (B) PCR analysis of the
MHV-68 and MHV-76 genomes. PCR amplification was performed on
viral DNA templates using primers specific for M1, M2, M3, M4, and
gp150 as indicated. Reaction products were analyzed on a 1% agarose
gel. Molecular size markers and their sizes in kilobase pairs are indi-
cated to the left. (C) Schematic diagram (not to scale) showing the
structures of the left ends of the MHV-68 and MHV-76 genomes. The
open arrows indicate protein-coding regions, and the small arrowheads
indicate the vtRNA genes. The open rectangle in MHV-76 indicates
residual M4 sequence. TRs, terminal repeats.
5318 MACRAE ET AL. J. VIROL.
5. As reported previously (33), MHV-68 replicated efficiently,
attaining maximal titers at around 60 h p.i. MHV-76 replicated
with the same kinetics and attained titers similar to those of
MHV-68. Thus, there was no significant difference between
MHV-68 and MHV-76 in their ability to replicate in vitro.
MHV-76 is cleared more rapidly than MHV-68 from the
lung. The ability of MHV-76 to replicate productively in vivo
was assessed. Mice were infected with MHV-76 or MHV-68,
and the virus titer in the lungs was assessed at various times p.i.
by plaque assay. Figure 3B shows that the titers of infectious
MHV-68 peaked at day 6 p.i. and remained detectable through
day 12 p.i. In contrast, MHV-76 titers peaked at day 4 p.i. and
were undetectable at day 10 p.i. There was also a significant
quantitative difference between the maximal titers achieved by
each virus (MHV-68, 1.9 3 105 PFU/lung; MHV-76, 2.4 3 104
PFU/lung [P 5 0.001]). These results indicate that MHV-76
replicates productively in vivo but is cleared more rapidly than
MHV-68 from the site of primary viral replication.
MHV-76-induced splenomegaly is less marked than that
induced by MHV-68. To determine the extent of splenomegaly
after MHV-76 infection, the total number of splenocytes in
mice infected with MHV-76 or MHV-68 was determined. As
seen in Fig. 3C, MHV-68 induced a characteristic increase in
splenocyte number that peaked at 14 days p.i. MHV-76 infec-
tion also caused an increase in cellularity in the spleen, but the
peak was significantly lower than that detected after MHV-68
infection (P 5 0.01). In addition, maximal cell numbers were
achieved slightly earlier, at between 10 and 14 days p.i.
FIG. 3. Biological characterization of MHV-76. (A) Single-step growth curves of MHV-68 (f) and MHV-76 (E) on BHK-21 cells at an MOI
of 5. Data are shown as mean log10 virus titer 6 standard error and are representative of two separate experiments, each carried out in duplicate.
(B) Viral replication in the lungs of BALB/c mice infected intranasally with 2 3 105 PFU of MHV-68 (f) or MHV-76 (E). The mean log10 virus
titer 6 standard error for four mice per group is shown for each time point. (C) Numbers of spleen cells during intranasal infection of BALB/c
mice with 2 3 105 PFU of MHV-68 (f) or MHV-76 (E). The mean total number of splenocytes 6 standard error for four mice per group is shown
for each time point. (D) Latent virus in the spleens of BALB/c mice infected with 2 3 105 PFU of MHV-68 (f) or MHV-76 (E) as determined
by infective-center assay. Infectious virus titers (less than 50 PFU per spleen) were subtracted from the infective-center results. The mean number
of infective centers per spleen 6 standard error for four mice per group is shown for each time point.
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MHV-76 establishes latency in the spleen but at much lower
levels than MHV-68. To investigate the ability of MHV-76 to
establish latency in vivo, mice were infected and latent virus in
the spleen was measured using an infective-center assay. The
results are shown in Fig. 3D. MHV-68 infective centers were
detected at around day 7 p.i. and peaked at day 14 p.i. In
contrast, latent MHV-76 in the spleen peaked at day 10 p.i.,
and the amount of latent virus was very much less (day 10, P 5
0.003; day 21, P , 0.001). MHV-76 infective centers were still
detectable at 31 days p.i., at levels of approximately 5 per 107
splenocytes. This indicates that MHV-76 can establish latency
in the spleen cell population but at much-reduced levels com-
pared to MHV-68.
To check that MHV-76 did not have an altered cellular
tropism in the spleen, we harvested spleens at 14 days p.i. and
fractionated cells into CD191 cells (B lymphocytes) and
CD192 cells (non-B cells) using magnetic cell sorting as de-
scribed previously (9). The purity of the separated fractions
was tested by fluorescence-activated cell sorter analysis and
found to be .95%. The two cell fractions as well as the total
cell population were analyzed for the presence of latent virus
using the infective-center assay. Greater than 90% of the in-
fective centers present in the splenocytes were present within
the CD191-B-cell subpopulation (not shown). A small amount
(,5%) of latent virus was also detected in the CD192 frac-
tions. Thus, the distribution of the MHV-76 within different
cell types in the spleen during splenomegaly appears to be
similar to that of MHV-68 (35), in that the majority of infective
centers were associated with B lymphocytes.
MHV-76 maintains long-term persistence in the spleen and
lung. The results of the infective-center assays described above
demonstrated that MHV-76 was able to establish latency dur-
ing the first 30 days of infection, albeit at a lower level than
MHV-68. To ascertain whether MHV-76 is subsequently
cleared or is able to persist, mice were infected with MHV-76
and MHV-68. After 5 months, organs from these mice were
analyzed for the presence of virus. Three of the four mice were
positive for MHV-76 infective centers in the spleen, at levels of
approximately 1 to 2 latently infected cells per 107 splenocytes.
No infectious virus was detected in this organ by plaque assay.
To analyze the presence of persisting virus in other organs,
DNA was extracted from the livers, lungs, kidneys, spleens, and
white blood cells of four MHV-76-infected mice at 5 months
p.i. Organs from one mouse infected with MHV-68 were also
harvested at 5 months p.i as a positive control, and those from
two uninfected mice were harvested as negative controls. Ex-
tracted DNA was analyzed for the presence of the viral ge-
nome by PCR amplification using primers specific for MHV-68
gp150, followed by Southern blot hybridization with a gp150-
specific probe to confirm the identity of the products. For each
set of PCRs, samples containing purified viral DNA or no
DNA were included as positive and negative controls, respec-
tively. Using known amounts of cloned template, it was deter-
mined that this process was sensitive to 1 to 10 copies of the
viral genome in 1 mg of high-molecular-weight DNA (not
shown).
As shown in Fig. 4A, viral DNA was not detected in either
of the uninfected mice. In agreement with our previous find-
ings (32), viral genomes were detected in the spleens and lungs
of the MHV-68-infected mouse but not in the blood or other
organs. Viral DNA was found in spleens of all four mice
infected with MHV-76 but in the lungs of only one of these
mice. To address the possibility that MHV-76-infected mice
may have been contaminated with MHV-68, we tested the
same DNA samples by PCR using primers specific for the
MHV-68 M3 gene, which is absent from MHV-76. Figure 4B
shows that the M3 sequence was detected only in the MHV-
68-infected mouse and not in any of the MHV-76-infected or
uninfected mice. The inability to detect the M3 sequence con-
firmed that the MHV-76 viral stocks were free of MHV-68 and
that the persisting virus in MHV-76-infected mice was defi-
nitely MHV-76.
These results show that MHV-76 is able to persist as effi-
ciently as MHV-68 in the spleen but that it was not as efficient
at persisting in lungs.
The inflammatory response is greater in the lung during
MHV-76 infection than during MHV-68 infection. The results
described above show that there were clear differences be-
tween MHV-76 and MHV-68 in their ability to replicate pro-
ductively in the lung and cause splenomegaly. This was prob-
ably due to differences in the host response to the virus, as
there was no intrinsic difference in the ability of the viruses to
replicate in vitro. As a preliminary response to this hypothesis,
we undertook a histopathological study of organs after infec-
tion, examining the lungs and spleens of infected mice at var-
ious times p.i. Representative results are shown in Fig. 5.
At 4 days p.i. with MHV-76, there was a marked inflamma-
tory response in the lungs, consisting of perivascular lymphoid
infiltrates and edema. Subpleural lymphoid accumulations
were also seen at this time p.i. (not shown). In contrast, no
inflammatory response was observed at day 4 p.i. in the lungs
of MHV-68-infected mice. By day 6 p.i., the inflammatory
changes seen during MHV-76 infection were more severe and
extensive than those on day 4, consisting of perivascular and
interstitial lymphoid infiltration, thickened alveolar walls, and
vasculitis. In contrast, the inflammatory changes were less pro-
nounced in MHV-68 infection at day 6 p.i., consisting mostly of
perivascular and interstitial lymphoid aggregations. At later
times (days 8 and 10 p.i.), the inflammatory responses follow-
ing MHV-76 and MHV-68 infections were similar (not shown).
These results demonstrate that the inflammatory changes
seen in the infected lung occur earlier and are more substantial
with MHV-76 than with MHV-68.
In the spleens of both MHV-68- and MHV-76-infected mice
at day 10 p.i., there was evidence of follicular hyperplasia as
revealed by germinal center formation and an increase in the
marginal zone of the white pulp. However, the differences
between the two groups, if any, were marginal and hard to
quantify by histopathology alone (not shown).
Construction of rescuant viruses. To determine definitively
whether the differences observed between MHV-76 and -68
were due to deletion of genes at the left end of the genome or
to unidentified mutations elsewhere in the genome, we con-
structed rescuants by cotransfecting MHV-76 genomic DNA
with MHV-68 cosmid A8 into BHK-21 cells. Since rescuants in
which the deletion was restored were likely to be less attenu-
ated in vivo, the progeny were passaged in mice. Spleens were
harvested, and virus was reactivated using an infective-center
assay. Plaques were screened for the presence or absence of
the M2 gene by PCR and assessed as representing pure viral
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clones on the basis of the presence or absence of M2 from all
subsequent plaques.
Three progeny clones were selected for further character-
ization. MHV-76(cA81)3 and MHV-76(cA81)4 were both
positive for M2 and thus represented rescuants in which the
deleted region had been restored. MHV-76(cA8-)5 was nega-
tive for M2 and thus represented unrestored MHV-76, which
had been subjected to in vivo passage in precisely the same way
as the rescuants. To check the genome structures, HindIII and
EcoRI digests were analyzed by Southern blot hybridization
using MHV-68 cosmid A8 as a probe. The results are shown in
Fig. 6A. Cosmid A8 contains sequences from MHV-68 HindIII
B, C, E, G, I, J, N, S, T2, U2, and Z2 (Fig. 1B). HindIII E, J, and
U2 are absent from MHV-76, and the remaining part of
HindIII J is present in a novel fragment containing the termi-
nal repeats. This fragment (JD) and T2 should thus appear as
a faint ladder of bands increasing to substantial sizes in in-
crements of 1.2 kbp. As expected, rescuant viruses MHV-
76(cA81)3 and MHV-76(cA81)4 yielded profiles identical to
that of MHV-68, and HindIII E was absent from MHV-76 and
MHV-76(cA8-)5. HindIII S and Z2 were too small to be
present on the blot. Hybridization to fragments containing the
FIG. 4. Detection of MHV-76 DNA in the tissues of mice at 5 months p.i. Four BALB/c mice were infected with 2 3 105 PFU of MHV-76,
and the lungs, livers, spleens, kidneys, and blood were harvested at 5 months p.i. Two uninfected mice were also harvested as negative controls,
and one mouse infected 5 months previously with MHV-68 was harvested as a positive control. Viral DNA was extracted, and PCR amplification
was performed on 1 mg of high-molecular-weight DNA. Samples containing MHV-68 viral DNA as a template (first lanes) or lacking DNA (second
lanes) were used as positive and negative controls, respectively. (A) PCR amplification using primers specific for gp150. PCR products were
analyzed by Southern blot hybridization with a 32P-labeled gp150 probe to confirm specificity. (B) PCR amplification using primers specific for M3
(a gene absent from MHV-76). PCR products were analyzed by Southern blot hybridization with a 32P-labeled M3 probe to confirm specificity.
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terminal repeats (U2
1, T2
1, and JD1) appeared as high-mo-
lecular-weight products, and the laddering normally associated
with such fragments was too weak to be detected. The same
blot was reprobed with a fragment containing full-length M3
which crosses the boundary between HindIII E and J. Figure
6B shows that both fragments are present in MHV-68 and the
two rescuants but absent from MHV-76 or MHV-76(cA8-)5.
These data indicate that the sequence absent from MHV-76
was restored in MHV-76(cA81)3 and MHV-76(cA81)4.
Sequence analysis of the region containing nucleotide 12280,
which is a G residue in MHV-68 but an A residue in MHV-76,
showed that the rescuants contain a G residue and MHV-
76(cA8-)5 contains an A residue. This is consistent with rescue
not only of the deleted sequences in MHV-76 by cosmid A8
but also of adjacent sequences.
We also analyzed viral DNA by PCR using primers specific
for M1, M2, M3, and M4. The results are shown in Fig. 6C.
ORF 74 primers amplified fragments of the anticipated size
from all three viral DNA samples. Primers specific for M1, M2,
M3, and M4 generated appropriately sized products from the
rescuants but not from MHV-76(cA8-)5. PCR of the viral
stocks produced the same results (not shown). This confirms
that M1, M2, M3, and M4 were restored in the rescuants but
not in MHV-76(cA8-)5.
Evidence that the rescuants were derived from MHV-76.
Variation in the copy number of reiterated sequences has been
shown to occur in MHV-68 (1). Therefore, we utilized the copy
number of the 100-bp repeat to assess the origin of the rescu-
ants. Viral DNA was digested with HincII and analyzed by
Southern blot hybridization using a radiolabeled BamM probe,
which is predicted to hybridize to a fragment containing the
100-bp repeat and to an adjacent fragment of 5,032 bp. The
results are shown in Fig. 6D. The MHV-68 fragment contain-
ing the 100-bp repeat was approximately 2.4 kbp in size,
whereas that derived from MHV-76 was 4 kbp. A fragment of
approximately 4 kbp was identified in both rescuants and
MHV-76(cA8-)5, except that MHV-76(cA81)3 also produced
a fragment of 3.4 kbp. These results show that the copy number
in MHV-68 DNA is approximately 22, as described previously
(42). However, MHV-76 and three derived viruses contained a
larger number (approximately 37 copies), and a subpopulation
of MHV-76(cA81)3 also contained an intermediate number
(approximately 30). These results are consistent with deriva-
tion of the rescuants from rescued MHV-76 rather than from
FIG. 5. Histopathological changes in the lungs of mice infected with MHV-76 or MHV-68. Representative sections of lung and spleen stained
with hematoxylin and eosin are shown for mice infected for the times indicated. Salient pathological features are highlighted as follows: P,
perivascular infiltration; BV, blood vessel; I, interstitial infiltration; V, vasculitis.
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FIG. 6. Molecular characterization of rescuant viruses. (A) Autoradiograph of a Southern blot of a 0.8% agarose gel showing the results of
hybridizing radiolabeled MHV-68 cosmid A8 to the HindIII products of DNAs isolated from BHK-21 cells infected with MHV-76, MHV-68,
MHV-76(cA81)3, MHV-76(cA81)4, and MHV-76(cA8-)5. The sizes of molecular size markers (in kilobase pairs) are shown on the left, and
HindIII fragments are shown on the right (see Fig. 1B for a map). (B) Autoradiograph of a Southern blot of a 0.8% agarose gel showing the results
of hybridizing radiolabeled M3 probe (nucleotides 6060 to 7277 in the MHV-68 genome) to the HindIII products of DNA isolated from BHK-21
cells infected with MHV-76, MHV-68, MHV-76(cA81)3, MHV-76(cA81)4, or MHV-76(cA8-)5. The sizes of molecular size markers (in kilobase
pairs) are shown on the left, and HindIII fragments are shown on the right (see Fig. 1B for a map). (C) PCR analysis of viral DNA from
MHV-76(cA81)3, MHV-76(cA81)4, or MHV-76(cA8-)5 using primers specific for the MHV-68 M1, M2, M3, and M4 genes and ORF 74.
Reaction products were analyzed on a 1% agarose gel. Molecular size markers and their sizes are shown to the left, with sizes in kilobase pairs.
(D) Autoradiograph of a Southern blot of a 0.8% agarose gel showing the results of hybridizing a radiolabeled BamHI M probe (which contains
the 100-bp repeat) to the HincII products of DNA isolated from BHK-21 cells infected with MHV-76, MHV-68, MHV-76(cA81)3, MHV-
76(cA81)4, or MHV-76(cA8-)5. The sizes of molecular size markers (in kilobase pairs) are shown on the left. Fragments containing the 100-bp
repeat, with approximate sizes, are indicated on the right, along with the adjacent 5,032-bp fragment present in each genome.
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contaminating MHV-68. Since MHV-76(cA81)3 contained
variable numbers of this repeat domain, we did not include this
rescuant in any further biological analyses.
The viruses are indistinguishable in vitro. To investigate the
effect of the deletion on viral replication in vitro, single-step
growth curves of MHV-68, MHV-76, MHV-76(cA81)4, and
MHV-76(cA8-)5 were compared (Fig. 7A). All four viruses
replicated with the same kinetics and attained similar maximal
titers at around 60 h p.i. There was no indication that the
deleted sequence had any effect on lytic replication in BHK-21
cells.
A lack of M1, M2, M3, M4, and the vtRNA genes leads to
attenuation in the lung. Mice were infected with MHV-68,
MHV-76, MHV-76(cA81)4, or MHV-76(cA8-)5, and the vi-
rus titer in the lungs was assessed at various times p.i. by plaque
assay. As shown in Fig. 7B, MHV-68 and MHV-76(cA81)4
achieved peak titers at around 7 days p.i. and were cleared by
14 days p.i. MHV-76 and MHV-76(cA8-)5 achieved similar
maximum titers, but the decrease in titer from this peak oc-
curred earlier and was more rapid [MHV-68 versus MHV-76
at day 7 p.i., P 5 0.037; MHV-76(cA81)4 versus MHV-76 at
day 7 p.i., P 5 0.010]. These data show that the deletion leads
to a significant attenuation of infection in the lungs.
Deletion of M1, M2, M3, M4, and the vtRNA genes severely
attenuates virus pathogenicity in the spleen. Mice were in-
fected with MHV-68, MHV-76, MHV-76(cA81)4, or MHV-
76(cA8-)5, and the extent of ensuing splenomegaly was deter-
mined by counting the total number of splenocytes and the
FIG. 7. Biological characterization of MHV-68, MHV-76, and the rescuant viruses. Data points (mean value 6 standard error) are shown in
each graph for MHV-68 (f), MHV-76 (E), MHV-76(cA81)4 (), and MHV-76(cA8-)5 (). (A) Single-step growth curves comparing growth of
viruses on BHK-21 cells at an MOI of 5. The data are representative of two separate experiments, and each experiment was done in duplicate.
(B) Viral replication in the lungs of BALB/c mice infected intranasally with 2 3 105 PFU of virus. Data for four mice per group are shown at each
time point. (C) Numbers of spleen cells during intranasal infection of BALB/c mice with 2 3 105 PFU of virus. Data for four mice per group are
shown at each time point. (D) Latent virus in the spleens of BALB/c mice infected with 2 3 105 PFU of virus as determined by infective-center
assay. Infectious virus titers (less than 50 PFU per spleen in every case) have been subtracted from the infective-center results. Data for four mice
per group are shown at each time point.
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increase in latently infected cells as monitored by infective-
center assay. The results are shown in Fig. 7C and D. After
infection with MHV-68 or MHV-76(cA81)4, there was a
sharp increase in splenocyte number, peaking at around 14
days p.i. However, after infection with MHV-76 or MHV-
76(cA8-)5, there was only a modest rise in splenocyte number,
peaking earlier at around day 10 p.i. [MHV-68 versus MHV-
76, P 5 0.003; MHV-76(cA81)4 versus MHV-76, P 5 0.005].
In mice infected with MHV-68 and MHV-76(cA81)4, in-
fective centers rose sharply from day 7 p.i. to a peak at day
14 p.i. Infective centers from mice infected with MHV-76 and
MHV-76(cA8-)5 were detectable in the spleen, but the peak
occurred earlier (day 10 p.i.) and was significantly less [MHV-
68 versus MHV-76, P 5 0.002; MHV-76(cA81)4 versus MHV-
76, P 5 0.008]. However, latently infected cells were detected
in mice infected with MHV-76(cA8-)5 or MHV-76 even at the
latest time point tested (32 days p.i.). These data show that the
deleted sequence contributes significantly to splenomegaly and
the acute rise in latently infected cells in the spleen but is not
essential for the establishment of latency and persistence.
DISCUSSION
This work describes a primary analysis of a novel murine
gammaherpesvirus, MHV-76. The genome of this virus was
found to be essentially identical to that of MHV-68, with the
single major difference being the absence of 9,538 bp at the left
end of the unique region of the genome. MHV-76 replicated
similarly in cell culture and had similar biological properties as
MHV-68, but it appeared to be significantly less pathogenic in
vivo in the context of a much more rapid and intense inflam-
matory response in the lungs. Recombinant viruses that had
the deletion in MHV-76 rescued had biological properties sim-
ilar to those of MHV-68.
MHV-68 was reported as having been isolated from the
bank vole, C. glareolus (3), whereas MHV-76 was described as
an independent isolate derived in the same study from the
yellow-necked wood mouse, A. flavicollis. Our data strongly
suggest that MHV-76 is a deletion mutant derived from MHV-68
or an extremely similar virus during passage. It is formally
possible that this could have occurred in nature, since Clethri-
onomys and Apodemus species share similar habitats. This
question is an important one and is currently being addressed
by the investigation of free-living rodent samples from the
United Kingdom.
MHV-76 lacks 9,538 bp containing the M1, M2, M3, M4, and
vtRNA genes. We have shown that MHV-76 and MHV-68
differ dramatically in their pathogenic potential in mice. This
could be due to the deletion or to unidentified mutations
elsewhere in the genome. Consequently, we utilized rescuants
in which the deleted region in MHV-76 had been restored by
recombination with MHV-68 sequences. Replacement of the
deleted sequence changed the phenotype of MHV-76 to one
that was not significantly different from that of MHV-68. This
shows definitively that the left end of the MHV-68 genome is
nonessential for viral productive replication but plays a key
role in pathogenesis. It is overwhelmingly likely that the key
determinants are located in the deleted sequence. However,
our results have not formally ruled out the possibility that the
single nucleotide substitution at nucleotide 12280, resulting in
replacement of a glycine by a serine residue in the ORF 6
protein, may play a role. We consider this unlikely, since a
deleterious point mutation (unlike a deletion) can readily re-
vert and is unlikely to survive under selection in mice. We are
also encouraged to view this residue as noncritical, since it is
not conserved in an independently isolated murine herpesvirus
in which the ORF 6 protein is 91.3% identical to that of
MHV-68 (it is an asparagine [S. Milligan, C. Chastel, S. Efsta-
thiou, and A. J. Davison, unpublished data]).
The left end of the MHV-68 genome appears to have a
propensity for undergoing recombination events in vitro (28).
This could be due to the proximity of multiple terminal repeats
or to the presence of highly transcribed vtRNA genes or a
putative origin of replication (4). Naturally occurring deletions
have been described for other gammaherpesvirus genomes.
The strains of Epstein-Barr virus in the Raji, Daudi, and
P3HR-1 cell lines all carry deletions of various sizes (15). For
HVS, spontaneous deletions at the left end of the genome have
been described (16). Indeed, the heterogeneity of the left end
of the HVS genome has been held responsible for the onco-
genic potential of the virus (19, 20). It is also of note that the
left end of the HVS genome encodes seven small viral RNAs
(2).
Unique genes at the left end of the genome have attracted
considerable attention in other gammaherpesviruses as well as
in MHV-68. In Kaposi’s sarcoma-associated herpesvirus, this
region contains the K1 gene, which shows unusual levels of
divergence in different virus isolates (45) and has been associ-
ated with cellular transformation (17). In HVS, this region
contains the STP gene, which is required for cellular immor-
talization and oncogenesis (16, 23), as well as the HVS small
viral RNAs (2). In Epstein-Barr virus, this region encodes
LMP-1, a classic oncoprotein that is essential for B-cell im-
mortalization (15). For MHV-68, however, less is known about
the function of the genes in this region and their contribution
to viral pathogenesis. Indeed, only the function of M3 has been
identified, as a soluble chemokine binding protein (25, 40)
potentially subverting the inflammatory response. Deletion of
M1 had no phenotypic effect on viral replication in vitro or in
vivo (6, 28), although one study implicated this region of the
genome in the regulation of latency (6). Also, deletion of
vtRNA genes 1 to 4 had no effect on viral pathogenesis (28).
Our studies confirm and extend these findings in demonstrat-
ing that genes M1, M2, M3, and M4 and all eight vtRNA genes
are nonessential for lytic virus replication in vitro and in vivo
and for the establishment and maintenance of latency in vivo.
Functions encoded at the left end of the MHV-68 genome
are nevertheless involved in virus pathogenicity. The more
rapid clearance from the lungs characteristic of MHV-76, com-
bined with an enhanced inflammatory response, indicates a key
role for this region in the avoidance of restrictions placed on
viral productive replication, for example, via interferons or the
immune response. The M1, M3, M4, and vtRNA genes are
transcribed during lytic infection (29, 41) and thus potentially
play roles in infection of the lung. Previous studies have ana-
lyzed MHV-68 mutants lacking M1 (6, 28) but did not assess
viral replication in the lung after intranasal infection.
The dramatically smaller extent of splenomegaly and lower
number of infective centers observed during MHV-76 infec-
tion constitute the first evidence that genes at the left end of
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the MHV-68 genome are specifically involved in splenomegaly
and generation of latently infected B cells. It is not clear,
however, precisely which of the known genes is responsible. M2
and the vtRNA genes are candidates, since they are tran-
scribed during latent infection of splenocytes (14, 29). M2 is
also expressed predominantly in B cells during splenomegaly
(38). M1, M3, and M4 have not been shown definitively to be
associated with latency (14, 41) but may still have a role in
splenomegaly, since low levels of productive viral replication
occur in the spleen during the establishment of latency. Che-
mokines play an important role in directing the migration of
leukocytes to sites of inflammation (18). Thus, the chemokine-
binding actions of M3 may play an important role in spleno-
megaly. One report has implicated M1 in the suppression of
viral reactivation (6). However, the effect was observed only at
later time points in peritoneal exudate cells after intraperito-
neal infection. In addition, that study employed recombinant
viruses containing the human cytomegalovirus immediate-
early promoter, which may in itself affect MHV-68 replication.
A suppressive effect of M1 was not observed in our experi-
ments.
Both MHV-76 and MHV-68 persisted in the spleens of
infected mice for at least 5 months p.i. Thus, the genetic ele-
ments necessary for this process are clearly not present in the
left unique portion of the genome. However, the persistence of
MHV-76 in the lungs was much less consistent, occurring in
only one of four mice. Long-term persistence of virus in the
lung is a consistent feature of MHV-68 infection (32). Thus,
although the numbers are low, our data suggest that sequences
missing in MHV-76 are important for long-term persistence in
the lung. The more rapid and intense inflammatory response
seen in the lung during MHV-76 infection may indicate that
the virus is more effectively cleared from this site by the host
response. In addition, there may be subtle variations in ge-
nome copy number in the spleen that are influenced by the
locus absent in MHV-76. These questions await the results of
quantitative experiments on DNA load over an extended time
course.
In summary, we have demonstrated that a region of the
genome containing M1, M2, M3, M4, and the vtRNA genes
plays a key role in infection in mice by MHV-68, probably
though evasion of the host innate defense mechanisms and
immune response. Ongoing studies in this laboratory are ex-
pected to reveal the contributions of individual genes.
MHV-76 is anticipated to be a useful virus from which to
construct appropriate mutants.
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